A Practitioner’s Guide to Prescribing Valproate for Adults with Intellectual Disabilities

作者: Jose de Leon

DOI: 10.1007/978-1-4614-2012-5_21

关键词:

摘要: We developed this valproate guideline using drug prescribing ­information and reviewing the available literature on relevant neuropsychiatric disorders in populations without intellectual disabilities because of dearth population with disabilities. This includes indications; contraindications; assessments prior to during treatment; dosing particular focus modifications required by drug–drug interactions, personal characteristics or genetic variants; adverse reactions. The procedures contained may not fully account for all possible risks treatment limited studies available; thus, there will be a need periodically update as new information becomes available. Nevertheless, we believe that provides useful resource clinicians who treat epilepsy, mood disorders, and/or challenging behaviors adult individuals A utilization review summarizes is described.

参考文章(202)
Charles B. Nemeroff, Michael J. Owens, Pharmacology of valproate. Psychopharmacology Bulletin. pp. 17- 24 ,(2003)
Dubovsky Sl, Buzan Rd, Thomas M, Firestone D, Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults. The Journal of Clinical Psychiatry. ,vol. 56, pp. 529- 532 ,(1995)
Leslie Citrome, Schizophrenia and valproate. Psychopharmacology Bulletin. pp. 74- 88 ,(2003)
Lynda G Johnson, C Thomas Gualtieri, Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed : Medscape general medicine. ,vol. 8, pp. 46- ,(2006)
Dumoulin L, Landry P, Plasma concentration of valproate following substitution of divalproex sodium by valproic acid. The Canadian Journal of Psychiatry. ,vol. 45, pp. 761- ,(2000)
Edoardo Spina, Concetta DʼArrigo, Vincenza Santoro, Maria Rosaria Muscatello, Gianluca Pandolfo, Rocco Zoccali, Francisco J Diaz, Jose de Leon, Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder. Therapeutic Drug Monitoring. ,vol. 31, pp. 758- 763 ,(2009) , 10.1097/FTD.0B013E3181C0590E
Katherine E. Burdick, Joseph F. Goldberg, Cognitive side effects of anticonvulsants. The Journal of Clinical Psychiatry. ,vol. 62, pp. 27- 33 ,(2001)
Elinor Ben-Menachem, Weight issues for people with epilepsy--a review. Epilepsia. ,vol. 48, pp. 42- 45 ,(2007) , 10.1111/J.1528-1167.2007.01402.X